FACTORS ASSOCIATED WITH TIME TO DISABILITY PROGRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS

被引:2
|
作者
Arteaga-Noriega, Anibal [1 ,2 ]
Castro-Alvarez, John Fredy [3 ]
Benjumea-Bedoya, Dione [2 ]
Gutierrez-Vargas, Johanna [3 ]
Segura-Cardona, Angela [1 ]
Gonzalez-Gomez, Difariney [4 ]
Zapata-Berruecos, Jose [1 ,5 ]
机构
[1] Univ CES, Epidemiol & Biostat Res Grp, Medellin, Colombia
[2] Remington Univ Corp, Family & Community Hlth Res Grp, Medellin, Colombia
[3] Remington Univ Corp, Neurosci & Aging Res Grp, Medellin, Colombia
[4] Univ Antioquia, Natl Sch Publ Hlth, Medellin, Colombia
[5] Neurol Inst Colombia, Medellin, Colombia
关键词
multiple sclerosis; Multivariate Analysis; disability evaluations; CEREBELLAR CORTEX; DEMYELINATION; DIAGNOSIS;
D O I
10.17843/rpmesp.2022.394.11433
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. To determine the sociodemographic, clinical and radiological factors associated with time to disability progression in patients with multiple sclerosis (MS). Materials and methods. Cross-sectional descriptive study with an analytical component, based on clinical records of patients at the Neurological Institute of Colombia, between 2013 and 2021. Progression to disability in MS patients was defined as the time to an increase of at least 0.5 points in the EDSS (Expanded Disability Status Scale) score, sustained for at least six months. A Cox regression model was used to estimate the survival function and Hazard Ratios (HR) with their 95% confidence intervals (95% CI). Results. We included 216 patients, of whom 25% progressed to disability, median survival was 78 months (95% CI: 70-83), active lesions (HR = 1.94; 95% CI: 1.10-3.44), cerebellar complications (HR = 2.03; 95% CI: 0. 99-4.16), being male (HR = 2.5; 95% CI: 1.32-4.73), and having neurological diseases (HR = 2.18; 95% CI: 1.03-4.61) were associated as risk factors. While relapsing remitting MS (HR = 0.63; 95% CI: 0.31-1.26) and age at diagnosis less than 40 years (HR = 0.96; 95% CI: 0.53-1.76) were associated as protective factors. . Conclusions. Progression is affected by many factors, and there is no single independent factor.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 50 条
  • [1] Prognostic factors associated with long-term disability and secondary progression in patients with multiple sclerosis
    Aurencao, I.
    Thuler, L. C. S.
    Alvarenga, R. M. P.
    Vasconcelos, C. C. F.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E297 - E298
  • [2] Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Kallenbach Aurencao, Juliana Calvet
    Santos Thuler, Luiz Claudio
    Camargo, Solange
    Alvarenga, Marcos Papais
    Papais Alvarenga, Regina Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 27 - 34
  • [3] Cerebrovascular risk factors and progression of disability in multiple sclerosis
    Lily, O.
    Selvarajah, J.
    Spilker, C. E.
    Ford, H.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S45 - S45
  • [4] Loss of gyrification is associated with disability progression in multiple sclerosis
    Silva, Jonadab Dos Santos
    La Rosa, Francesco
    Mullins, William A.
    Parvathaneni, Prasanna
    Maranzano, Josefina
    Reich, Daniel
    Beck, Erin
    NEUROLOGY, 2023, 100 (17)
  • [5] Telomere Length Is Associated with Disability Progression in Multiple Sclerosis
    Krysko, Kristen M.
    Henry, Roland G.
    Cree, Bruce A. C.
    Lin, Jue
    Caillier, Stacy
    Santaniello, Adam
    Zhao, Chao
    Gomez, Refujia
    Bevan, Carolyn
    Smith, Dana L.
    Stern, William
    Kirkish, Gina
    Hauser, Stephen L.
    Oksenberg, Jorge R.
    Graves, Jennifer S.
    ANNALS OF NEUROLOGY, 2019, 86 (05) : 671 - 682
  • [6] Psychiatric comorbidity is associated with disability progression in multiple sclerosis
    McKay, Kyla A.
    Tremlett, Helen
    Fisk, John D.
    Zhang, Tingting
    Patten, Scott B.
    Kastrukoff, Lorne
    Campbell, Trudy
    Marrie, Ruth Ann
    NEUROLOGY, 2018, 90 (15) : E1316 - E1323
  • [7] Prognosic factors associated with disability in multiple sclerosis
    Shulga, O.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [8] Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis
    Sayonara Rangel Oliveira
    Tamires Flauzino
    Beatriz Sardinha Sabino
    Ana Paula Kallaur
    Daniela Frizon Alfieri
    Damacio Ramon Kaimen-Maciel
    Helena Kaminami Morimoto
    Elaine Regina Delicato de Almeida
    Marcell Alysson Batisti Lozovoy
    Edna Maria Vissoci Reiche
    Isaias Dichi
    Andréa Name Colado Simão
    Metabolic Brain Disease, 2018, 33 : 1393 - 1399
  • [9] Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis
    Oliveira, Sayonara Rangel
    Flauzino, Tamires
    Sabino, Beatriz Sardinha
    Kallaur, Ana Paula
    Alfieri, Daniela Frizon
    Kaimen-Maciel, Damacio Ramon
    Morimoto, Helena Kaminami
    Delicato de Almeida, Elaine Regina
    Batisti Lozovoy, Marcell Alysson
    Vissoci Reiche, Edna Maria
    Dichi, Isaias
    Colado Simao, Andrea Name
    METABOLIC BRAIN DISEASE, 2018, 33 (05) : 1393 - 1399
  • [10] Effect of smoking on disability progression in patients with multiple sclerosis
    Gunduz, Tuncay
    Kurtuncu, Murat
    TOBACCO INDUCED DISEASES, 2018, 16 : 28 - 28